반응식
CC(C)([O-])C.[K+].CO[C:9](=[O:21])[C:10]([C:12]1[C:20]2[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=2)[NH:14][CH:13]=1)=O.[CH3:22][N:23]([CH2:25][C:26]1[CH:34]=[CH:33][C:32]2[N:28]([C:29]([CH2:36][C:37]([NH2:39])=[O:38])=[C:30]([CH3:35])[CH:31]=2)[CH:27]=1)[CH3:24].[NH4+].[Cl-]>O1CCCC1.CCOC(C)=O>[CH3:22][N:23]([CH2:25][C:26]1[CH:34]=[CH:33][C:32]2[N:28]([C:29]([C:36]3[C:37](=[O:38])[NH:39][C:9](=[O:21])[C:10]=3[C:12]3[C:20]4[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=4)[NH:14][CH:13]=3)=[C:30]([CH3:35])[CH:31]=2)[CH:27]=1)[CH3:24]참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
Potassium tert-butoxide (1.0 M in THF, 0.24 ml, 0.24 mmol, 3.0 equiv) is added dropwise at room temperature under an atmosphere of argon to a solution of (1H-indol-3-yl)-oxo-acetic acid methyl ester (19.2 mg, 0.090 mmol, 1.1 equiv) and of 2-(6-dimethylaminomethyl-2-methyl-indolizin-3-yl)-acetamide (20 mg, 0.08 mmol) in anhydrous tetrahydrofuran (1.0 ml, dried over molecular sieves). The reaction mixture is stirred for 30 minutes at room temperature. It is then diluted with EtOAc and poured into a saturated aqueous NH4Cl solution. After three extractions with EtOAc, the combined organic layers are dried over Na2SO4, filtered and concentrated in vacuo. Purification of the residue via preparative HPLC affords the title compound (2 mg, 6%) as its trifluoroacetate salt. 1H NMR (400 MHz, d6-DMSO): δ=11.78 (s, 1H), 10.91 (s, 1H), 9.51 (s, 1H), 8.33 (s, 1H), 7.99 (d, J=2.9 Hz, 1H), 7.54 (s, 1H), 7.35 (d, J=8.1 Hz, 1H), 7.03 (d, J=9.1 Hz, 1H), 6.95 (dt, J=8.0/1.2 Hz, 1H), 6.61 (dd, J=9.3/1.3 Hz, 1H), 6.52 (dt, J=8.1/1.0 Hz, 1H), 6.17 (d, J=8.0 Hz, 1H), 4.13 (s, 2H), 2.67 (s, 6H), 1.93 (s, 3H). MS (ES+): 399 (M+H)+.
후처리
- extractionAfter three extractions with EtOAc
- dry with materialthe combined organic layers are dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification of the residue via preparative HPLC
출처 및 근거
- ORD 기록
- ord-2a4e5e20c76743ffb926b4445ec659f1
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08193236B2
연결된 노트
불러오는 중…